Augustine Therapeutics
About:
Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases
Website: https://www.augustinetx.com/
Top Investors: Eli Lilly, Asabys Partners, PMV, VIB, AdBio partners
Description:
Augustine Therapeutics company is a two drug discovery programs to identify novel generations of selective HDAC6 inhibitors for the treatment of axonopathies such as Charcot Marie Tooth disease. These new compounds have the potential to protect from nerve degeneration and promote peripheral myelin and axon repair.
21.2M EUR
$1M to $10M
Leuven, Vlaams-Brabant, Belgium
2019-03-01
contact(AT)augustinetx.com
Bart De Strooper, Joris De Wit, Ludo Van den Bosh
1-10
2024-06-26
Private
© 2025 bioDAO.ai